Exchange: NYSE
Industry: Drug Manufacturers/Major
Last Trade: 4:01 PM ET 2/9/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.88 | 0.91 | -3.30 |
| EPS, GAAP | 0.00 | 0.00 | NA |
| Consensus Estimate | 0.95 | 0.88 | 7.95 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.59 | 3.54 | 1.41 |
| EPS, GAAP | 2.49 | 1.40 | 77.86 |
| Consensus Estimate | 3.62 | NA | NA |
| GSK | Industry Average | |
| P/E (TTM) | 17.81 | 17.80 |
| P/E (Forward) | 11.43 | 13.00 |
| PEG Ratio | 1.66 | 2.45 |
| Price/Sales | NA | 2.54 |
| Beta | 0.61 | 0.61 |
| 1:16 PM | 2/8/2012 | GlaxoSmithKline Buys Back 575,000 Shares |
| 11:33 AM | 2/8/2012 | ChemoCentryx IPO Up 12% After Cutting Price |
| 2/9/2012 | Pharma Looks Ripe for Rebound (WSJ.com) |
| 2/9/2012 | Just the facts, Fool. (The Motley Fool) |
| 2/9/2012 | Facebook Alternatives: Less Hype, More Hope (WSJ.com) |
| 2/8/2012 | Finding companies that have all the right stuff can produce winners. (The Motley Fool) |
| 2/8/2012 | Greece talks weigh on FTSE 100 (MarketWatch.com) |
| 2/7/2012 | Glaxo Has Been Repatriating Euro-Zone Cash (WSJ.com) |
| 2/7/2012 | Glaxo Slips After Disappointing Earnings, Diabetes Drug Sales (Barrons.com) |
| 2/7/2012 | To Outsource Or Not to Outsource? That's the Pharma R&D Question (WSJ.com) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
